The medical-derm patient and the cosmetic-derm patient are not the same patient. The insurance flow and the cash-pay flow are not the same flow. We separate them at the front door and keep them separated all the way through.
The medical patient (insurance, recurring, AED 500-2,000 chemical peel; AED 800-2,500 microneedling per session) sees the same creative as the cosmetic patient (cash, single-procedure, AED 1,500-6,000 HIFU or RF microneedling per session, Zavis 2026).
Conversion suffers in both. Most clinics never see this because the agency reports on aggregate. We disaggregate. Dermatology no-show rates can run as high as 30% (Prospyrmed 2025).
Insurance-driven. Recurring. Care plan. The unit economic is the third visit, not the first. The reporting metric is treatment completion rate, not lead volume.
Cash-pay. Single procedure. Decision velocity is fast, lead-time is short. The unit economic is the package upgrade, not the entry visit. Different copy, different cadence, different reporting.
They do not realise dermatology and aesthetics overlap legally. The clinic ends up either turning them away (lost revenue) or scrambling to fit them in (operational chaos). The qualification needs to happen at the form, not at the front desk.
A skin clinic downstairs runs aggressive cosmetic ads. Patients arrive at the dermatology clinic upstairs expecting the same prices. The clinic loses the conversation before it starts because the patient was qualifying the wrong door.
Summer kills laser demand in the GCC. Most agencies do not adjust the funnel; they keep spending against an audience that is not ready to book until October. The medical-derm track stays steady. The cosmetic track needs a different calendar.
Two campaigns. Two landing-page systems. Two reporting columns. Qualification at the form level. The voice agent triages medical or cosmetic at first response, then routes to the right human or the right calendar.
One audience, one landing page, blended reporting. The clinic owner sees a single conversion number that hides two very different stories. Operational chaos at the front desk. Margin loss in both segments.
Medical-derm campaign with insurance-aware copy and pre-auth coordinator workflow. Cosmetic-derm campaign with editorial creative, cost-cap bid strategy, and re-treatment cadence. Two reporting columns, one operating layer.
Compliance overlay. Cosmetic creative falls under DHA Standard ST-21 v1.1; medical creative falls under standard health-advertising rules. Both pre-approved by the Medical Director before launch. Detail on the methodology page.
The medical-derm patient enters the funnel here. A “what is this on my skin?” diagnostic guide captures email at a meaningful rate. Long nurture follows. The conversion is relationship-built, not click-built.
Patches versus rash. Itch profile. When to escalate. When the over-the-counter route is appropriate. When to book the consult.
Plaque versus guttate. Triggers worth tracking. The biologics conversation. The dermatologist's role in the long arc.
Hormonal versus inflammatory. The over-the-counter trial period. Tretinoin etiquette. When the in-clinic protocol becomes the right answer.
The guide does not diagnose. It educates. No certainty language. No outcome promises. Every page reviewed by the clinic's lead dermatologist before publication, and refreshed annually.
Laser hair removal, hydrafacial, IPL, HIFU, RF microneedling. Cosmetic dermatology in the GCC carries some of the highest CPCs in the digital advertising market. The bid strategy and the creative register both have to earn the click.
Cost-cap with hard ceilings. We are not chasing volume on a vertical that punishes loose bidding.
Narrow geo, 3-7km radius. Evening dayparting on cosmetic decisions; the patient researches at night.
Editorial, not clinical. Magazine-grade creative. Compliance-checked under DHA ST-21 v1.1 every variant.
Medical dermatology in the UAE is largely an insurance category. Eczema, psoriasis, suspected mole work-up, fungal, paediatric. The patient is checking two things on the call: whether she is covered and whether the clinic knows how to file it. The agency that does not know the major UAE providers by name is asking the receptionist to do work that should already have happened on the form.
Cash-pay and insurance are tracked as separate columns from day one. The same procedure carries different LTV in each bucket; blending the numbers obscures what the clinic is actually winning and losing. Major UAE insurance providers and their dermatology coverage tiers are populated during pilot week one, not promised in advance. The data is accurate when the work is done, not when the slide deck is approved.
The booking flow integrates an image upload at the form, AI pre-screen for routing only, then doctor review. The DoH and DHA telehealth rules apply; we follow them by name, not by analogy.
Two routes. The pilot cohort, or a dermatology-specific audit on your inbox by end of week.
Besnik responds inside one working day from Dubai.
